Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS: PVCT · Delayed Price · USD
0.190
-0.006 (-3.18%)
Apr 26, 2024, 3:23 PM EDT - Market open
PVCT Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.03 | 0.02 | 0.68 | 0.1 | 0.59 | 0.05 | 0.11 | 1.17 | 14.18 | 17.39 | Upgrade
|
| Cash & Cash Equivalents | 1.03 | 0.02 | 0.68 | 0.1 | 0.59 | 0.05 | 0.11 | 1.17 | 14.18 | 17.39 | Upgrade
|
| Cash Growth | 4652.60% | -96.84% | 602.43% | -83.54% | 1058.57% | -51.67% | -90.95% | -91.78% | -18.47% | 10.80% | Upgrade
|
| Receivables | 0 | 0 | 0.01 | 0 | 0.06 | 0.6 | 0.45 | 0.3 | 0.5 | 0.73 | Upgrade
|
| Inventory | 0 | 1.41 | 2.42 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Current Assets | 0.34 | 0.47 | 0.33 | 0.32 | 0.35 | 0.37 | 0.4 | 0.36 | 0.04 | 0.98 | Upgrade
|
| Total Current Assets | 1.36 | 1.9 | 3.44 | 0.42 | 1 | 1.02 | 0.96 | 1.83 | 14.72 | 19.1 | Upgrade
|
| Property, Plant & Equipment | 0.08 | 0.14 | 0.07 | 0.17 | 0.25 | 0.07 | 0.09 | 0.07 | 0.09 | 0.09 | Upgrade
|
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0.82 | 1.47 | 2.69 | 0 | Upgrade
|
| Intangible Assets | 0 | 0 | 0 | 0 | 0.23 | 0.9 | 1.57 | 2.24 | 2.91 | 3.58 | Upgrade
|
| Other Long-Term Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 3.41 | Upgrade
|
| Total Long-Term Assets | 0.08 | 0.14 | 0.07 | 0.17 | 0.48 | 0.97 | 2.48 | 3.78 | 5.72 | 7.08 | Upgrade
|
| Total Assets | 1.45 | 2.04 | 3.51 | 0.59 | 1.48 | 1.99 | 3.44 | 5.61 | 20.44 | 26.18 | Upgrade
|
| Accounts Payable | 1.68 | 2.09 | 1.29 | 0.96 | 1.13 | 3.31 | 3.27 | 1.92 | 1.89 | 0.44 | Upgrade
|
| Deferred Revenue | 0.95 | 1.51 | 2.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Current Debt | 3 | 2.11 | 1.74 | 23.71 | 0.58 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Current Liabilities | 3.39 | 2.48 | 2.17 | 6.04 | 1.32 | 0.79 | 0.73 | 0.22 | 2.24 | 0.41 | Upgrade
|
| Total Current Liabilities | 9.02 | 8.19 | 7.7 | 30.71 | 3.02 | 4.1 | 4 | 2.14 | 4.12 | 0.85 | Upgrade
|
| Long-Term Debt | 0.03 | 0.07 | 0 | 0.08 | 19.8 | 13.93 | 9.46 | 0 | 0 | 0 | Upgrade
|
| Other Long-Term Liabilities | 0 | 0 | 0 | 0 | 2.73 | 1.37 | 0 | 1.92 | 1.89 | 0.15 | Upgrade
|
| Total Long-Term Liabilities | 0.03 | 0.07 | 0 | 0.08 | 22.53 | 15.3 | 9.46 | 1.92 | 1.89 | 0.15 | Upgrade
|
| Total Liabilities | 9.04 | 8.27 | 7.7 | 30.8 | 25.55 | 19.41 | 13.46 | 2.14 | 4.12 | 0.99 | Upgrade
|
| Total Debt | 3.03 | 2.18 | 1.74 | 23.8 | 20.37 | 13.93 | 9.46 | 0 | 0 | 0 | Upgrade
|
| Debt Growth | 38.52% | 25.26% | -92.67% | 16.80% | 46.24% | 47.34% | - | - | - | - | Upgrade
|
| Common Stock | 0.42 | 0.42 | 0.42 | 0.4 | 0.39 | 0.38 | 0.37 | 0.36 | 0.2 | 0.18 | Upgrade
|
| Retained Earnings | -252.69 | -249.59 | -246.03 | -240.49 | -233.82 | -226.89 | -218.74 | -205.22 | -180.8 | -156.29 | Upgrade
|
| Comprehensive Income | -0.06 | -0.04 | -0.03 | -0.03 | -0.02 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shareholders' Equity | -7.59 | -6.23 | -4.19 | -30.21 | -24.07 | -17.42 | -10.02 | 3.47 | 16.32 | 25.19 | Upgrade
|
| Total Liabilities and Equity | 1.45 | 2.04 | 3.51 | 0.59 | 1.48 | 1.99 | 3.44 | 5.61 | 20.44 | 26.18 | Upgrade
|
| Net Cash / Debt | -2 | -2.16 | -1.06 | -23.7 | -19.78 | -13.88 | -9.35 | 1.17 | 14.18 | 17.39 | Upgrade
|
| Net Cash / Debt Growth | - | - | - | - | - | - | - | -91.78% | -18.47% | 10.80% | Upgrade
|
| Net Cash Per Share | -0.00 | -0.01 | -0.00 | -0.06 | -0.05 | -0.04 | -0.03 | 0.00 | 0.07 | 0.10 | Upgrade
|
| Working Capital | -7.65 | -6.29 | -4.26 | -30.29 | -2.03 | -3.09 | -3.04 | -0.32 | 10.6 | 18.26 | Upgrade
|
| Book Value Per Share | -0.02 | -0.01 | -0.01 | -0.08 | -0.06 | -0.05 | -0.03 | 0.01 | 0.08 | 0.14 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.